Search Results - "Shohara, L"

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC) by O’Cearbhaill, R.E., Wolfer, A., Disilvestro, P., O’Malley, D.M., Sabbatini, P., Shohara, L., Schwarzenberger, P.O., Ricciardi, T., Macri, M., Ryan, A., Venhaus, R.R., Bryan, J.K., Wong, P., Homicsko, K., Kandalaft, L., Rusakiewicz, S., Harari, A., Monk, B.J., Coukos, G.

Get full text

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC): Genomic sequencing and updated efficacy results by O'Cearbhaill, R.E., Homicsko, K., Wolfer, A., DiSilvestro, P.A., O'Malley, D.M., Sabbatini, P., Orcurto, A., Barras, D., Shohara, L., Ricciardi, T., Macri, M., Ryan, A., Venhaus, R.R., Monk, B.J., Coukos, G.

Get full text

945PA phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC) by O'Cearbhaill, R E, Wolfer, A, Disilvestro, P, O'Malley, D M, Sabbatini, P, Shohara, L, Schwarzenberger, P O, Ricciardi, T, Macri, M, Ryan, A, Venhaus, R R, Bryan, J K, Wong, P, Homicsko, K, Kandalaft, L, Rusakiewicz, S, Harari, A, Monk, B J, Coukos, G

Get full text

Flexible Interpretations: A Computational Model for Dynamic Uncertainty Assessment by Hardt, Shohara L

“…The investigations reported in this paper center on the process of dynamic uncertainty assessment during interpretation tasks in real domain. In particular, we…”
Get full text